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ABSTRACT 
Tendon injury can occur from activity-induced overuse, complete laceration or 
aging-related degeneration and these injuries commonly fail to wound heal without 
clinical treatment. Moreover, activity-induced overuse accounts for approximately half of 
all sports injuries and has highest occurrence rates in athletes playing football, baseball 
and basketball. Current non invasive technique to rest and ice the damaged tissue in 
combination with either oral NSAIDS or corticosteroid injections has shown little 
promise with only ~60% of cases regaining functionality of the tendon (Paterno et al., 
2013).  
From the literature, this seems to be caused by a combination of poorly perfused tissue 
along with a lack of cellular control throughout the inflammatory and remodeling phases 
of wound healing. Because of this, new generations of experimental therapies involve 
implementing a cocktail of growth factors and cytokines in an effort to control and 
perhaps expedite the wound healing process. In order for this approach to become 
clinically effective, improvements must be made in our understanding of TIMP-MMP-
COL interaction as well as chemokine-induced differentiation of involved macrophages 
(Morita et al., 2017; Martinez et al., 2014). This thesis considers the differential gene 
expressions between healthy and diseased tendons for further insight into tendon 
pathophysiology and possible improvements in therapeutic approach. 
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CHAPTER ONE 
INTRODUCTION AND RESEARCH AIMS 
1.1 Motivation 
The long-term goal of this thesis is to improve my understanding of the 
underlying molecular and cellular mechanisms, which lead to tendinopathy.  In order to 
accomplish this, I took a systems biology perspective observing significant differential 
gene expressions between healthy and disease state from previously published microarray 
data on NCBI. This in combination with a review of the literature gave a more robust 
theory about why tendons often fail to properly wound heal. Original methods of this 
research design followed PCA in attempt to tag differentially significant gene expression 
levels to a specific disease state. Upon approaching this topic I found many areas within 
the original methods of microarray data collection and microarray normalization that 
raise concerns about the significance of statistics applied to the array data. 
 In order to implement statistical methods for preliminary results without design-
specific concerns of microarray collection and normalization the Bioconductor package 
in R was used with functions previously created for use on microarray data. Because of 
this lack of significance, statistical observations of interest were based on what has been 
previously seen in the literature and findings from log-fold change expression analysis. 
Current work shows issues in the inflammatory signaling pathways of both tenocytes and 
macrophages as well as control of extracellular matrix anabolism and catabolism (Scott et 
al., 2011; Morita et al., 2017). Because of this, methods were refined for observation of 
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significant changes in chemokines of the interleukin family, matrix metalloproteinases, 
tissue inhibitor of metalloproteinases and collagen production.  
My future career goals are to improve my understanding of biomolecular 
engineering, cellular/molecular biology and computational modeling in order to approach 
complex problems such as this one with a combination of finite element modeling (FEM) 
and bioinformatics. As I approach PhD candidacy in BDSI I will hold close to improving 
my understanding of this topic and further refined statistical methods. I am also hopeful 
to find the opportunity to apply the tools that I have gained from this research towards a 
dissertation surrounding the topic of cancer physiology.  
1.2 Research Aims 
In this study we observe significant changes in gene expression between healthy 
and diseased tendons through differential expression with sample weighting and principal 
component analysis. We will look for evidence supporting what has been previously 
shown in literature with respect to expressions of matrix metalloproteinases, tissue 
inhibitor of metalloproteinases and collagen types. Future iterations of this study should 
consider GSEA in order to represent a more defined separation between healthy and 
diseased states as well implementation of these statistics on mRNAseq data pertaining to 
the topic instead of microarray. 
1.3 Significance 
Activity-induced overuse accounts for approximately half of all reported sports 
injuries and current treatments have proven to be relatively ineffective. Non invasive 
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technique to rest and ice the damaged tissue in combination with either oral NSAIDS or 
corticosteroid injections has shown little promise with only ~60% of cases regaining 
functionality of the tendon.  There is a need for novel therapies able to control the cellular 
and molecular mechanisms at hand in tendon pathology. However, this is a relatively new 
approach that will require a more robust understanding of cellular signaling than 
previously stated in the literature in order to be a safe and effective therapeutic. 
The three grand challenges of engineering most accurately applied to my research 
goals are to engineer better medicines, advance health informatics and engineer tools for 
further scientific discovery. As medicine continues to become more personalized and 
focused on molecular causation and drug targeting, computational tools including 
informatics and FEMs are becoming more and more a necessity to take observations on 
complex biological problems with a large amount of inputs. Engineering safer and more 
effective therapeutics plays a major role in bioengineering and is often the framework of 
interesting biological questions. With respect to this thesis as well as a large amount of 
informatics work, statistical proof of molecular interactions often leads to new 
understandings of pathophysiology.  
This informatics perspective in combination with review of the literature may also 
lay the groundwork for an FEM in attempt to observe changes in tendon physiology over 
time with respect to genes of interest as inputs. This continued reiteration of modeling 
and collecting statistics is key to expediting the translation of biomedical bench top work 
into clinical applications.  
8 
CHAPTER TWO
LITERATURE REVIEW
2.1 Introduction 
Tendons are composed of connective tissue and function as mechanical 
connections between musculature and bones surrounding a specific joint, acting as levers 
for locomotion. Tendons have also been noted to have high tensile strength and minimal 
plastic deformation in order to transmit heavy loads. These mechanical properties present 
a structure to function relationship as seen in Figure 2.1 with triple helices of 
tropocollagen fibers compacted into fibrils along a single axis.  
Each step of this hierarchy from fibril to fascicle tissue level has a thin layer of 
reticular cartilage called the endotenon, which allows for subunits to move independently 
without frictional damage. At the tendon level this reticular cartilage is defined separately 
as endotenon (inner) and epitenon (outer). Finally, some tendons have a true synovial 
sheath encasing the epitenon with a thin layer of synovial fluid in between called the 
paratenon. This functions as protection from friction on a larger scale and is seen most 
commonly in high-stress tendons where loading can be significantly greater than total 
body weight such as the achilles and peroneal tendons of the ankle. 
9 
Figure 2.1: Tendon Structure: Collagen Type 1 ECM 
 Tropocollagen is a ~300nm long triple-helix protein which is made 
thermodynamically favorable via its high amount of hydroxyproline and proline 
residues.  Hodge and Petruska concluded from transmission electron microscopy (TEM) 
that tropocollagen has a one-fourth staggered arrangement when formed into fibrils. This 
means that for every five proteins aligned laterally in the overlap region, there are four 
molecules lateral to the gap as seen in Figure 2.2. These intermittent extra spaces are 
filled by proteoglycans and glycosaminoglycans (GAGs) whose function is thought to aid 
in the protection of tenocytes from compressive forces (Parvizi et al., 2010). 
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Figure 2.2: Tropocollagen Arrangement within a Fibril (Parvizi et al., 2010) 
 Known as a dense regular connective tissue, the majority of a tendons 
composition is water weight, with collagen type 1 making up 85% of it’s dry weight; 
collagen type 3 makes up 5% and proteoglycans make up about 0-5% of total dry weight. 
They maintain a small cell population of tenocytes defined as spindle like fibroblastic 
cells running along the axis of loading and responsible for collagen production as well as 
initial cellular response to injury (Orthobullet, 2016). It has been noted in the literature 
that under pathologic condition tenocytes shift from a “spindle-like” morphology into 
rounded cells. Furthermore, the healthy morphology aids in cell-to-cell communication 
and mechanotransduction. These finger-like extensions surround and attach to bundles of 
collagen via membrane bound integrin receptors in order to produce a continuous cellular 
response to cyclic-loading. Secondly, these extensions also form gap junctions from cell 
to cell allowing for a synergic response to changes in local physiology (Parvizi et al., 
2010).  
This poses an interesting question about the origin of tendinopathy. Causation via 
disoriented ECM has been previously accepted as the initial cause of disease, but it may 
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be more plausible that disease state is caused by disordered and poorly anchored 
tenocytes attempting to regain connection to collagen ECM and other cells perpendicular 
to the axis of loading (Smith et al., 2010). Although it will not be discussed very heavily 
in this thesis, it should be noted that cyclic-loading in a rehabilitative manner plays a vital 
role in proper tendon healing and further research must be done in order to improve the 
timing of clinical methods towards more improved response by tenocytes. 
Tendon pathology can occur from overuse, laceration or age related degeneration, 
but the underlying issues in regenerating healthy tendon from all three of these 
pathologies are similarly marked by poor perfusion, a lack of cellular response and weak 
control over the timing of inflammatory and remodeling processes (Paterno et al., 2013). 
2.2 Tendon Biomechanics 
Tendons are considered a mechano-adaptive tissue type meaning that they are 
capable of altering their structure and cellular functioning based on mechanical inputs 
from its surrounding environment. It has been shown that physical activity can have 
anabolic effects similar to that of micro tearing in musculature wherein tendon diameter 
increases via new ECM production. This gives tendons the increased tensile strength 
needed in order to continue undergoing high intensity exercises. However, at some 
threshold of microscopic failure the tendon becomes pathologic and can no longer correct 
damages to its ECM efficiently. This is marked by disorganized matrix, reduced 
mechanical properties, and proliferation of disease state tenocytes (Wang et al., 2012). 
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Figure 2.3: Tendon Stress-Strain Curve (Wang et al, 2012) 
Figure 2.3 above shows a general tendon stress-strain curve with the 
‘physiological range’ being regular activity induced strain at a maximum of around 4%. 
The linear region defines the point when the collagenous ECM is uncrimped and 
withstands over 4% lengthening before causing microscopic failures. Strains above 8% 
will likely cause macroscopic rupture (Wang et al., 2012). It is also important to note that 
tendons have been shown to have viscoelastic properties meaning that it responds to 
strain with both elastic and plastic deformation based on rate of the force applied. The 
elastic deformation can be seen above within the argument of ‘crimped’ collagen 
structure stretching as an initial response to strain. Creep strain occurs when the tendon is 
held at a constant stress and plastic deformation continues to occur causing an increase in 
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strain. This leaves the tendon with slightly weaker mechanical properties after heavy use 
from physical activity and if not rested properly will lead to overuse injury. 
2.3 Injury and Repair 
Figure 2.4: Time Scale of General Wound Healing Process (William et al., 2008) 
Natural wound healing occurs in 3 major steps; Inflammation or hemostasis, 
proliferation and remodeling. Inflammation is the body's immediate response to injury, 
which is initialized by platelets plugging the damaged area to avoid continued blood loss. 
During this phase M1 phagocytic macrophages are recruited to the damaged site in order 
to begin clearing debris whether it be infectious material, dead cells or disorganized 
ECM. Fibroblastic cells producing new ECM is a common characteristic of the 
proliferation phase of wound healing, but in tendons this ECM is often in high amounts 
of collagen type 3 instead of type 1. The fibroblastic cells producing new ECM are a mix 
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of tissue resident tenocytes as well as activated M2 macrophages. In the final stage of 
wound healing disorganized collagen type 3 is broken down and remodeled into 
organized ECM with an increase in collagen type 1 composition as seen in healthy tissue 
(Lin et al., 2004; Martinez et al., 2014). 
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Chapter Three
Literature Review: Microarray, Normalization and PCA 
3.1 Biomedical Constraints 
While the work done by Jelinsky and others has aided our understanding of 
tendinopathy and its fibrosis-like pathologic characteristics, there are still many areas of 
biological diversity that have not been previously considered in the investigation of 
tendon microenvironments. Firstly, the most obvious biological constraints are 
differences in sex and age. The Jelinsky study was majority male (65%) and 83% of 
patients were above the age of 45 with a maximum age of 66. There was one 32 year-old 
male that was included in the study with a 10 year age difference between he and the rest 
of the cohort. In terms of model bias, this tells us that the expression results are somewhat 
skewed toward a male population with age-related degeneration. While these are obvious 
differences within the cohort, they are not likely to be the major factors of variation 
within the gene expression results.  
Seemingly more interesting, is the variation amongst anatomic location of tissue 
collection and past history of corticosteroid injections. The majority of the cohort had 
rotator cuff damage accounting for 70% of cases. Beyond this the study included two 
extensor carpi radialis brevis (ECRB) tears, two flexor tendon tears, two patellar tendon 
tears and one distal bicep tear. This may be a more major factor in the causation of 
variation in results, because these tendons have cell populations that are inherently 
different due to their location and function. It may be more sensible to consider 
17 
expression analysis for only RTC tears and reduce cohort size from 23 to 16. ECRB tears 
as well as the distal bicep tear are more likely to have negligible variation in comparison 
with RTC tears due to similar anatomic location and loading, but patellar and flexor 
tendon pathologies seem to be unintuitive inclusions. As described in chapter 2, flexor 
tendons have considerably different anatomy with specialized flexor sheaths in order to 
allow for small precise movements at high frequency without damage. Patellar tendon 
inclusion seems most surprising because of the load and frequency of impact encountered 
by lower limb tendons. These loads are significantly greater then RTC and ECRB 
tendons in the upper limb. All of these anatomic differences will lead to differing cell 
response and therefore different expressions across samples within analysis. Note that 
this affects both diseased and healthy tendon samples. Healthy sample selection differed 
amongst studies based on feasibility of access while biopsy was being performed at the 
disease site. For most RTC cases a healthy sample was collected from another 
subscapular tissue region or from healthy bicep tissue. Patellar tendon tear’s healthy 
counterparts were collected from the quadriceps and flexor tendon counterparts were 
collected from healthy tissues distal to the injury site. Further study that may be of 
interest could be a comparison of healthy and disease tissues with respect to their 
anatomical locations and then considering differences in expression across anatomical 
location. This may give further insight into specific tissue pathologies as well as an 
understanding of mechanical loading’s effect on expression and disease progression. 
Lastly the consideration of corticosteroid injections and their effects on cellular 
expression may be the most important area of biological variance within this study. The 
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study collected the number of steroid injections per patient. It’s a plausible assumption 
that this was collected for retrospective review, as it was not contained in the results or 
heavily within the discussion. Number of injections ranged from 1 to 3 and only 52% of 
the cohort received steroid injection. Further study in comparing steroid and non-steroid 
injection cohorts may give insight on how they change cellular expression and more 
interestingly the long term effects of corticosteroids on tendon pathology. The majority of 
works done in considering the efficacy of corticosteroids on mesenchymal cell lines only 
consider tissue health for one to three months after injection. There have also recently 
been retrospective studies on human corticosteroid injections due to the fact that patients 
return with complaints of returned pain. This tells us that the steroids are not a feasible 
long-term solution and that the pain returns with further damaged tissue. One of the most 
referenced alternatives to corticosteroids is autologous platelet rich plasma injections, 
which have been shown to improve pain intensity as well as physiological function long-
term. However, platelet rich plasma is not clinically available and corticosteroids have 
been shown to be more effective in immediate pain mitigation (Tang et al., 2019). 
Unfortunately, there was also no collection on the timing of the corticosteroid injections; 
how long prior to biopsy the injections were received or how far apart the injections were 
administered for those who received multiple injections. This would have been vital 
information for further studies considering the long-term efficacy of steroid injections. 
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3.2 Affymetrix Microarray 
Microarray is a laboratory tool that has allowed for the first generation of 
genomic-based research of disease. This has been made possible by microarray’s 
capabilities of collection and analysis on very large sets of data and is accomplished 
through hybridization of genomic fragments onto an array of oligonucleotide 
probes. Microarray allows us to collect an initial genome library for a specific species 
and then study changes in cell populations within the species; most notably ‘The Human 
Genome Project’.  In order to collect differential gene expression, mRNA is extracted 
from both test and control group and labeled separately with fluorescent dye as seen 
below in Figure 6 (Karakach et al., 2010). Methods in choosing probe type have varied 
since the origin of microarray based on differing theories of genetic precision and 
improved statistical value; discussed here are methods of Affymetrix GeneChip 
microarray as it pertains to the data used in this thesis.  
Figure 3.1: Microarray methods with Cy3 and Cy5 dyes marking control state and target 
expressions (Karakach et al., 2010) 
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Affymetrix uses the method of “probe sets” composed of 9 to 16 rather short 
probes (25 nucleotides in length) in order to account for non-specific binding and give a 
relative measure of noise present. Non-specific binding occurs when a ligand binds to 
something other than its target due to stochastic environment, collision theory and 
relatively strong mismatched affinity. This is often seen to cause noise in microarray. 
Affymetrix attempted to tackle this problem by placing both perfect match (PM) and 
mismatch (MM) probes within each probeset. This means that (PM) probes are composed 
of a 25 nucleotide transcripts targeting a gene of interest while the (MM) counterpart is 
an identical transcript with the exception of a single base replacement in the middle 
position (Karakach et al., 2010). Perfect match probes on these arrays were made bias to 
the 3’ end of their respective target genes in an attempt to avoid mRNA degradation bias 
and improve the unique characteristic of each probe for improved target precision (Penn 
State Stat 555, 2018). 
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Figure 3.2: Perfect Match (PM) Mismatch (MM) design for Affymetrix 
GeneChip (Penn State Stat 555, 2018) 
Unfortunately this attempt has been shown to be crowded with issues. This 3’ bias 
has been shown to instead cause weak probe hybridization and missing expressions from 
splice variants. Alternative splicing is a post-transcriptional regulating mechanism in 
which cells control which sections of an mRNA transcript will be processed through the 
translation step into a protein. Enzymes within the nucleus, which generally remove 
introns and leave exons intact, can alternatively choose to remove entire proteins from its 
code prior to sending the mRNA for translation. Therefore, Affymetrix 3’ bias fails to 
capture a certain portion of splice variants. Additionally, the MM probes have been 
unsuccessful in accounting for background and have been removed from new generations 
of microarray (Penn State Stat 555, 2018). 
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3.3 Normalization 
Normalization is an important biomedical research technique applied to data in 
order to remove unwanted noise that has been produced externally from the biological 
question at hand. A simple example applied to microarray; if data collection was done at 
separate time points, it is possible that all of the intensity values for one array will 
slightly be greater or less than all values of another. This is caused by changes in the 
intensity of the light bulb used in activating the luminescent mRNA. The most common 
way to account for these issues is called quantile normalization.  
Quantile normalization ranks all intensity values from each sample separately 
from one another and then takes a mean value across all samples for each ranked 
position, greatest to least. Now these mean values replace the originally ‘uneven’ values 
across each ranked set and rankings are indexed back to their specific gene expressions as 
seen in Figure 3.3.  
Figure 3.3: A simple illustration of Quantile Normalization 
(Starmer, StatQuest 2017)
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 While this has been shown to produce low variance and low bias with simplicity 
of its mathematical computing, it has also been found that quantile normalization can 
impact the biological differences within data raising questions about its effectiveness 
(Boes, 2005).  
 Returning to the discussion of (PM) and (MM) probes defining a probeset on 
Affymetrix arrays; although it has been shown to be inefficient compared to other array 
and mRNAseq techniques, these microarrays are still used for comparison to new data 
which requires probeset summarization as background correction beforehand. The initial 
model for probeset summary was an average difference between the PM and MM probes 
within a set such that PMij - MMij. As discussed earlier, this method was found to be 
unsuccessful and it has been noted to have multiplicative errors in intensity values, 
unaccounted for background variation and most concerning, greater intensity values from 
MM probes than PM probes.  
There have been many attempts in the literature to improve upon these issues in 
order to make this type of GeneChip array data viable. But, because there are so many 
normalization steps to be considered, transforming steps on data specific to Affymetrix 
GeneChips have been programmed within the R Bioconductor package in an attempt to 
standardized methods and report results back to literature for further improvement. 
 
3.4 Further Data Transformations and Bioconductor 
From normalization methods and microarray techniques discussed thus far, it is 
clear that there are many steps in which error may occur. Bioconductor is an ongoing 
NCBI project aimed toward expediting data transformations accounting for these errors 
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with standardized methods as well as providing plotting methods shown to be effective in 
previous work. Bioconductor uses the Gene Expression Omnibus as a compatible genetic 
expression repository allowing for genetic data analysis to be open to the scientific 
community. This standardization allows for more reproducible microarray results and the 
package has many different transformations based on differing types of microarray. After 
further study of the Affymetrix HGU133plus2 platform and Jelinsky’s methods, the 
original dataset was renormalized and further analyses were considered. Firstly, quantile 
normalization may not be the most sensible normalization technique. It is often used 
during RNAseq preprocessing. It may also apply to some microarray data based on the 
platform used, but for Affymetrix PM-MM probesets it has shown to be unintuitive. 
Jelinsky methods followed a previous paper observing the same biological phenomena a 
rat model. These methods were as follows; firstly the probsets from each sample were 
lowess (locally weighted scatterplot smoothening) normalized using a Bioconductor 
variation called MAS 5.0 in order to account for spot intensity variations. Jelinsky 
included a ‘soft’ set of MAS 5.0 lowess normalized sets in the GEO database as well as 
the raw cdf (raw intensity values) files.  Under consideration of simplicity and 
reproducibility, these soft files were used in later iterations of analysis. However, these 
GSEs still need to be transformed from normalized intensity values in order to 
graphically consider fold change. In order accomplish this, the set was separated into 
healthy (control) and disease state and mean intensity values were log2 transformed for 
input into a volcano plot. This visualization method allows for consideration of 
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significantly up regulated genes in combination with their significance with p-values 
calculated via a simple t-test across the control and disease sets. 
 
3.5 Principal Component Analysis 
 Principal component analysis (PCA) is a statistical method aimed toward 
capturing connections across an n-dimensional dataset and presenting them in a k-
dimensional subspace (where k <=n) for observation with a known percentage of 
variation captured. For simplicity, consider that there are only two genes of interest with 
sample counts that can be plotted on an x-y plane. Note that if there were more than three 
genes, we would not be able to graphically represent the problem due to dimensionality 
issues. Because of this, PCA aims to condense all of the data into fewer dimensions 
called principal components without changing sample counts magnitude relative to each 
other. It is most commonly reduced to two dimensions for easy observation, but many 
instances require more principal components in order to minimize the loss of data 
variation across samples. 
PCA accomplishes this by shifting the data such that its centroid is bound to the 
origin and then defines a line of best fit based on maximizing the sum of squared 
distances from each counts projection on the line to the origin. This finds the optimal fit 
for the data because the distance from the origin to the projection of each point is the 
inverse of the distance from each point to its projection on the line. This is depicted in 
Figure 3.4 where distance ‘a’ remains constant requiring lines ‘b’ and ‘c’ to be 
uncorrelated due to geometrical constraint. PCA uses this sum of squares method because 
it is the easier method to calculate. Even though minimizing distant ‘b’ may seem 
26 
intuitively correct the two approaches are equivalent. This line now defines principal 
component one, and its slope with respect to the original axes comparing two genes 
defines its covariance within the data.  
Figure 3.4: Illustrative Aid for Principal Component Analysis; (a) top left: initial 
sample scores, (b) top right: shifted scores with initial line defined, (c) bottom 
left: line approaching optimal fit by sum of squares and (d) bottom right: 
conceptualization of the inverse relationship between distances a and b within 
PCA methods. (Starmer, StatQuest 2018) 
The sum of squared distances from data projections onto any principal component 
is defined as that components eigenvalue. A principal components covariance for a two 
gene model describes the weighting that each gene had on the orientation of the 
component, thus giving insight to which gene may be causing differences in sample 
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clusters. Covariance is defined mathematically by each PC’s eigenvalue divided by the 
number of samples minus 1. An eigenvector is simply a unit vector bound to the origin 
and in the direction of any principal component, calculated by dividing both of its x and y 
projections on the original plane by its distance from the origin. The proportion of each 
gene contained in the eigenvectors projections are called loading scores. PC2 is simply a 
line perpendicular to PC1 and bound to the origin. Therefore, the eigenvector defining 
PC2 will be the inverse of PC1. 
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Chapter Four 
Methods in R, and Discussion of Results 
4.1 Methods 
A literature review was conducted to determine clinically relevant gene 
expressions within tendinopathy. From review, MMPs, TIMPS, chemokines related to 
inflammatory signaling, and collagen-producing genes were found to be the most 
relevant. Datasets were collected from the GEO database containing 46 microarray 
samples from 23 human patients (23 healthy site biopsies, 23 diseased site; 3 mm2  cuts). 
A two-tailed t-test was performed to compare the largest fold-change expressions from 
healthy to diseased states. A Principle Component Analysis was then performed. The 
goal of PCA is to show relationships between the scores of variable data and loadings of 
sample sets. In this regard, it should show specific genes and their likelihood of 
expression in a healthy and diseased tendon. The two-tailed t-test was performed on the 
relative expression set normalized by the original author, while normalization for PCA 
was done separately in R. From the previous study, each probe set was normalized to a 
mean signal intensity value of 100. The David Bioinformatics Database was used for 
conversions from probe ID to gene ID where necessary. 
To complete PCA, the raw sample sets were first quantile normalized by finding 
the ranked per-row mean across all samples and saved into  ‘micro_mean’.  These 
ranked-mean values were then indexed back into the original ‘micro’ dataset using 
micro$Gene_id. Probes with missing expression values were at this point removed across 
all samples and the new data frame saved into ‘df_final’ (lost 382 probes). Data was 
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collected for PCA variance ratios as well as scores and loadings along each principal 
component. Log2 fold-change normalization was later considered and observations were 
taken from Figure 4.3 and Table 4.3 below. 
4.2 Results 
From the literature, the genes found to have significant-fold change include 
ADAM12, POSTN, IL13RA2, IL-Beta, IL-6 and TNF-alpha. From differential 
expression, COL4A3 (p<0.05) was significantly down regulated in tendinopathy. This 
and other significant genes regulations are shown in the tables below with respective 
sample weighting shown. From PCA in R, covariance across PC1 and PC2 was 
unfortunately low at [5.33%, 4.26%] respectively. There was notable score clustering 
along principal component two.  These probes were converted and can be seen in Table 
4.2. Interestingly, the renormalized volcano plot showed up regulation of genes involved 
in cellular motility, division and differentiation as well as IL11, which have been 
previously studied with respect to the fibrosis pathway.  However, the more concerning 
result was the down regulation of a plethora of muscular probes such as troponin, myosin, 
and titin transcripts. 
30 
Table 4.1: Genes of significant differential expression, log fold change and weighting by 
sample Note: In table 2, GSM639748-GSM639770 (left) are healthy samples and 
GSM639771-GSM630793 (right) are disease samples. 
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Figure 4.1: Sample Loadings across PC1 and PC2 in R 
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Figure 4.2: Gene Scores Across PC1 and PC2 in R 
Table 4.2: Genes clustered along PC2 - 207733_x_at and 204927_at show high 
variable score, 204903_x_at and 213820_s_at show low score. 
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Figure 4.3: Volcano Plot of log2 fold-change probe values with adjusted p-values 
(Diseased up-regulation in the positive X direction). 
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Log2(Fold Change) Raw p-value Probe Names 
-6.55325 0.02999314 222287_at 
-6.183617 0.02739283 203861_s_at 
-5.555775 0.03837896 206844_at 
-5.253121 0.02821672 219772_s_at 
-5.212994 0.02968449 204810_s_at 
-5.152808 0.0215428 204865_at 
-5.152344 0.03471813 205177_at 
-5.144982 0.03291095 223572_at 
-5.07893 0.02735041 208084_at 
-4.858404 0.02473192 222954_at 
-4.85198 0.02600108 203863_at 
-4.706768 0.02394919 208083_s_at 
-4.615081 0.02695138 206768_at 
-4.412438 0.02125188 228406_at 
-4.347735 0.0322874 226228_at 
-4.319374 0.03313139 205163_at 
-4.314426 0.02129247 235367_at 
-4.203811 0.02251591 213201_s_at 
-4.173112 0.02858036 203862_s_at 
-4.159186 0.02144479 235261_at 
-4.146987 0.02354185 242729_at 
-4.130526 0.01164791 1553301_a_at 
-4.112497 0.02733729 242679_at 
Table 4.3: Significantly down-regulated probes: disease vs. control. 
Green = expressions related to muscle tissue-type (myosin, titin, and troponin transcripts) 
Yellow = actin alpha 2 transcripts 
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4.3 Discussion of Initial Normalization and PCA 
Due to such a low variance, results from PCA were not significant and used only 
to further consider what has been seen in the literature. Interestingly, three of the four 
probes identified have been shown to be involved in differentiation, remodeling and cell 
proliferation. As seen in Figure 4.2, clusters of healthy and diseased sample loadings 
along PC2 defined disease states.  
First we will discuss genes related to the healthy state cluster, followed by genes 
associated with the diseased cluster. RASSF7 is a Ras family associated protein, which 
has been studied most heavily on its regulations of actin cytoskeleton. It has been shown 
to play a role in negative regulation of apoptosis via JNK activation. Interestingly, JNK 
has been shown to be an apoptosis regulator based on stress-inducing stimuli as a part of 
the mitogen-activated protein kinase (MAPK) family. These stimuli include 
inflammation, oxidative stress, osmotic stress and cytoskeletal changes (Zeke et al., 
2016). The protein encoded by PSG9 belongs to the immunoglobulin superfamily. It has 
been studied most extensively in fetal development for cellular adhesion and is thought to 
inhibit platelet-fibrinogen interactions, and important pathway involved in inflammatory 
response (NCBI, PSG9).  
The two genes associated with the diseased cluster were ATG4B and STARD5.  
ATG4B is involved in the autophagy process in which damaged organelles and proteins 
are destroyed within a cell. It is considered to be a cellular homeostatic mechanism 
necessary for differentiation and non-apoptotic cell death, but studies of this gene are still 
in very early stages and mostly focus on its prevalence in colorectal cancers (NCBI, 
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ATG4B). Lastly, STARD5 seems to be involved in intracellular transport of sterols and 
other lipids to the endoplasmic reticulum, but involvement in tendinopathy or it’s 
underlying pathways has not been seen in the literature. 
From review of the literature, the majority of significant differentially expressed 
genes involved in tendinopathy are cytokine-producing and matrix remodeling 
genes. Cytokine-producing genes IL-1beta, IL-6 and TNF-alpha have been extensively 
studied for this application and from systematic review it has been shown that IL-6 is up-
regulated in damaged tendons as well as healthy tendons after exercise, while TNF-alpha 
and IL-1beta showed little significant fold change (Jelinsky et al., 2011).  
 From the original differential expressions, IL-13RA2 was also found to have a 
statistically significant fold change greater than five. IL-13RA2 produces specific protein 
units of the IL-13 receptor complex, which regulates the release and uptake of IL-13. 
Interestingly, IL-13 has been shown to promote macrophage differentiation into phase 
two phagocytic cells. In macrophages, the M2 phase of differentiation is a period in 
which the cell becomes active in producing new extracellular matrix and is an integral 
state of wound healing. IL-6 acts in a very similar manner, but IL-6 has been shown to be 
secreted by macrophages and recruit B-cells with pattern recognition for pathogenic 
debris.   
IL-1beta is the final inflammatory factor under consideration, and it was found to 
have no significant fold change in tendinopathy. This seems inconsistent when 
considering the normal pathway of cytokine up-regulation during an inflammatory 
response, but could be legitimized by the assumption of a ‘lack of inflammatory 
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response’ in tendinopathy. This makes sense because IL-1beta is expressed by activated 
macrophages and regulates their proliferation and differentiation. In order for this an IL-
1beta cascade to begin regulating macrophage activity they must be initially activated by 
cytokines from the damaged tissue site. Returning now to the argument of IL-13RA2 
expression, when significant damage occurs this gene is heavily up-regulated and blocks 
the release of IL-13 inhibiting macrophage activation and may be a factor in the observed 
weak inflammatory response. Obviously the issues involved in tendinopathy are not 
going to be solved by a single factor, but this data shows that improving our 
understanding of cytokine activity and its impact on inflammatory regulation will give 
further insight into the reasoning for why tendons fail to follow typical wound healing. 
Another factor to consider would be intracellular gene regulation pathways of these 
chemokines similar to those found from PCA. While reviewing the literature, it seemed 
that the most well defined genes are those of cellular response. Studying diseases from 
initial input through intracellular pathways to final cellular response will allow for a more 
holistic understanding of underlying issues. 
Other genes of importance to consider continued research in include ADAM12 
and COL4A3. These genes encode proteins functioning in matrix anabolism and 
catabolism respectively. Although these functions oppose each other, both are required 
for normal wound healing in which disintegrins and MMPS like ADAM12 breakdown 
damaged extracellular matrix while fibroblastic cells produce new collagenous 
extracellular matrix.  
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 Literature has shown a significant increase in ADAM12 expression, accounting 
for continuously worsening mechanical properties of the tendon as extracellular matrix is 
broken down (Jelinsky et al., 2011). Expression data has shown that COL4A3 is 
significantly down regulated in tendinopathy, meaning that new extracellular matrix 
proteins in this domain are not being produced. This shows a possible imbalance in 
extracellular matrix anabolism and catabolism, but collagen type 4 is not commonly 
present in tendons making observations seemingly less significant. 
4.4 Discussion of Secondary Normalization 
The secondary normalization and volcano plot gave further insight into the 
biomedical constraints of the original study and debates whether or not the control set 
was effectively selected. From section 3.1, it is seen that healthy tissue selection was 
determined based on feasibility during the disease state biopsy. But these healthy sites 
were often muscular regions, which is an unintuitive control for diseased tendon 
(majority subscapular, bicep and quadricep tissue). 
 Before considering this further, note that the original study filtered the original 
set around genes of interest, specifically collagen, cytokine, MMP and TIMP transcripts. 
While these expressions are biologically interesting with respect to the disease state, the 
absolute value of their log-fold change was smaller than any of the muscular expressions.  
From Fig 4.3 and Table 4.3, it is shown that down regulation of multiple myosin and 
troponin transcripts have absolute log fold-changes from 4-6 while the original 
interesting gene set lies within a 1-2 fold-change (Jelinsky et al.). From Jelinsky et al. and 
others, the role of the fibrosis pathway in tendinopathy is shown to be vital in our 
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understanding of cellular mechanisms at play, but such consistent down regulation of 
muscular expressions leads us back to the original sample selection. Reconsidering the 
original paper’s healthy sample selection, 52% of samples were from surrounding 
muscular tissue not healthy tendon. This evidence strengthens the argument that the data 
collected is skewed due to poor methods within collection (The Human Protein Atlas). 
It was also noted that multiple transcripts for the actin alpha 2 subunit were 
heavily down regulated as well. This is an interesting observation because it has been 
shown that cellular adhesion and motility changes drastically in the disease state. Actin is 
an intracellular filament that is involved in maintaining the structure and mechanical 
response of the cell. From chapter two, tenocytes at the disease site have been shown to 
lose ECM connection and form rounded cartilaginous cellular structure instead of healthy 
spindle-like arrangement. However, in considering again the healthy sample selection and 
muscular expression, it has been shown that act2 is expressed most heavily in muscular 
tissue as they have a continuously dynamic structure.  Therefore the heavy down 
regulation of act2 in the disease state seems to be another artifact of poor sample 
selection rather than true difference in tenocyte expression. 
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Chapter 5 
Conclusion & Future Implications 
5.1 Conclusion 
From the literature, tendinopathy seems to be marked by a combination of poorly 
perfused tissue along with a lack of cellular control throughout the inflammatory and 
remodeling phases of wound healing. Because of this, new generations of experimental 
therapies involve implementing a cocktail of growth factors and cytokines in an effort to 
control and perhaps expedite the wound healing process. As our understanding of cell 
biology continues to improve, especially in the area of stem cell therapy, it seems that 
these therapeutics could become effective medicines. Underlying this however is an 
understanding of many different pathways at hand all with a plethora of regulators 
changing based on stimuli upstream in their respective pathway. The most prominent 
pathways involved seem to be extracellular matrix metabolism and chemokine pathways. 
Interestingly, the chemokine pathways exist in a very dynamic system in which 
cell-signaling events occur from tenocytes to macrophages as well as amongst 
differentiating macrophage populations. Improvements in our understanding of cell 
differentiation and function in this area will help create a more clear picture of the 
underlying issues through considering each cell type as a separate but responsive system. 
While in theory this seems exciting, in order to study gene expressions of each cell type 
individually we must first jump major hurdles in defining and collecting separated 
populations.  
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From further consideration of the Jelinsky study within the renormalization step, 
it was shown that initial sample collection criteria needs to be improved upon in order to 
gain a more accurate understanding of the fibrosis pathway’s involvement in 
tendinopathy. This can be seen from Fig 4.3 and Table 4.3 above, in which the majority 
of significantly down regulated expressions are involved muscular tissue-type expression. 
This does not make the current findings within the literature on the effects of the fibrosis 
pathway in tendinopathy illegitimate, but it does raise concern about the original studies 
significance. 
5.2 Future Implications 
In terms of statistical analysis moving forward, further use of the Bioconductor 
package in R should be assessed so that we can view microarray data from an expression 
set in plots of multiple statistical analyses quickly for preliminary observation. Also, 
using the AFFY package within Bioconductor allows for comparison of results based on 
normalization types. While this is not helpful information toward a specific biological 
question, it may give insight on how microarray can be useful across applications and on 
how to safely use this tool without being lead down faulty paths due to insignificant 
observations. 
Gene Set Enrichment Analysis may be a better option for high throughput data 
than PCA especially on microarray data because it considers differential expression of 
gene sets aligning with Affymetrix libraries. It also takes a global pathway analysis 
perspective taking initial inputs as specified gene sets of interest and considers their 
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expression across two biological states. This could ultimately be used to consider MMP-
TIMP-ADAM-COL expression to further study ECM metabolism or chemokine 
inhibition and activation pathways to trace underlying cause of cellular response. An 
expedited GSEA was run across all human tissue types through the Msig database and its 
resulting heat map is within Appendix C. This analysis was completed for a significantly 
down-regulated set from our secondary normalization. Because of this, none of the 
fibrosis pathway transcripts were involved and it instead gave insight into initial sample 
collection similar to Table 4.3. Future iterations of GSEA may consider a comparison of 
disease state fibrosis transcripts against healthy skeletal muscle as background. This 
should show that the global pathway analysis completed in the original paper is a 
characteristic of differing tissue types more so than differing disease states. 
Another alternative statistical approach is linear discriminant analysis. LDA is 
very similar to PCA, except it looks to maximize the seperability of two categories.  It 
does this by defining its component similarly to PCA methods, but then check the ratio of 
each categories mean to scatter. High mean difference and low scatter is the optimal 
solution and allows the computer to better differentiate between disease states. 
RNAseq is the new generation of tools focused on collection of genetic 
information with major advantages compared to gene chip microarrays. As discussed 
earlier, microarray requires an initial library to be created in order to compare new arrays 
to an initially defined genome. RNAseq also has a much better signal to noise ration 
because probe specificity is much better than in microarray. This is because RNAseq has 
single base pair resolution via fluorescent tagging on each nucleotide within a sample and 
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fluorescently activating them pair-by-pair. Because of this advantage, RNAseq can 
compare a target gene to all of its isoforms and splice variants. This removes the need for 
an initial library to be created and allows for the possibility of finding novel gene 
expressions. This also makes RNAseq a much more sensible application for observation 
of differences between healthy and diseased cells by direct comparison.  
The major disadvantage of RNAseq is that it has been more expensive than 
microarray in the past decade. But the cost of RNAseq is dropping as methods in both 
data collection and processing continue to improve. Now that Seq technology is reaching 
a more affordable cost, research using these methods will likely increase and possibly 
replace microarray.   
5.4 References 
Irizarry, Rafael A, et al. “Gene Set Enrichment Analysis Made Simple.” Statistical 
Methods in Medical Research, U.S. National Library of Medicine, Dec. 2009, 
www.ncbi.nlm.nih.gov/pmc/articles/PMC3134237/. 
Chial, Heidi. Nature News, Nature Publishing Group, 2008, 
www.nature.com/scitable/topicpage/dna-sequencing-technologies-key-to-the-
human-828. 
Wang, Zhong, et al. “RNA-Seq: a Revolutionary Tool for Transcriptomics.” Nature 
Reviews. Genetics, U.S. National Library of Medicine, Jan. 2009, 
www.ncbi.nlm.nih.gov/pmc/articles/PMC2949280/. 
46 
Tang, Siqi, et al. “Platelet‐Rich Plasma versus Autologous Blood versus Corticosteroid 
Injections in the Treatment of Lateral Epicondylitis: a Systematic Review, Pairwise 
and Network Meta‐Analysis of Randomized Controlled Trials.” Wiley Online 
Library, John Wiley & Sons, Ltd, 17 Nov. 2019 
GSEA User Guide, software.broadinstitute.org/gsea/doc/GSEAUserGuideFrame.html 
47 
APPENDICES 
Appendix A 
PCA CODE IN R 
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Appendix B 
Creating an Expression Set in Bioconductor 
# Load Packages/Dependencies for Bioconductor
if (!"BiocManager" %in% rownames(installed.packages()))
install.packages("BiocManager")
BiocManager::install(c("affy", "limma"), dependencies=TRUE)
# AFFYMETRIX HG-U133 2 Plus annotation
BiocManager::install("hgu133plus2.db")
#AFFYMETRIX Methods for Analysis
BiocManager::install("affy")
BiocManager::install("simpleaffy")
if (!requireNamespace("BiocManager", quietly = TRUE))
install.packages("BiocManager")
BiocManager::install("GEOquery")
library(affy)
library(Biobase)
library(genefilter)
library(BiocGenerics)
library(limma)
library(GEOquery)
#Get expression data directly from GEO
gse <- getGEO("GSE26051",GSEMatrix=FALSE)
head(Meta(gse))
names(GSMList(gse))
GSMList(gse)[[1]]
# check names of the GPLs represented in case of different 
platforms across samples
#names(GPLList(gse))
gse26051 <- getGEO('GSE26051',GSEMatrix=TRUE)
show(gse26051)
#check names of the GPLs represented in case of different 
platforms across samples
gsmplatforms <- lapply(GSMList(gse),function(x) 
{Meta(x)$platform_id})
head(gsmplatforms)
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#Splt GSE into list of GSMs for expression set
gsmlist = Filter(function(gsm) 
{Meta(gsm)$platform_id=='GPL570'},GSMList(gse))
length(gsmlist)
Table(gsmlist[[1]])[1:5,]
probesets <- Table(GPLList(gse)[[1]])$ID
data.matrix <- do.call('cbind',lapply(gsmlist,function(x)
{tab <- Table(x)
    mymatch <- match(probesets,tab$ID_REF)
    return(tab$VALUE[mymatch])
}))
data.matrix <- apply(data.matrix,2,function(x) 
{as.numeric(as.character(x))})
data.matrix <- log2(data.matrix)
data.matrix[1:5,]
# Use Biobase subpackage to convert into an expression set 
for input into "affy" functions
require(Biobase)
rownames(data.matrix) <- probesets
colnames(data.matrix) <- names(gsmlist)
pdata <- data.frame(samples=names(gsmlist))
rownames(pdata) <- names(gsmlist)
pheno <- as(pdata,"AnnotatedDataFrame")
eset2 <- 
new('ExpressionSet',exprs=data.matrix,phenoData=pheno)
eset2
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Appendix C 
 GSEA of Down Regulated Expressions 
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Appendix D 
Volcano Plotting in R 
# Add packages
library(ggplot2)
library(Biobase)
library(genefilter)
library(affy)
library(BiocGenerics)
library(limma)
#Input raw GEO data -- define Gene_id as index % 
micro <- read.csv("Full Set_tagged.csv",TRUE,",")
#tags <- read.csv("Affymetrix tags")
gene_tags <- micro$Gene_id
micro$Gene_id <- NULL
# Separate healthy and diseased samples for t.test
micro1 <- micro[,1:23]
micro2 <- micro[,24:46] 
## Take mean intensity for H/D 
micro1_mean <- apply(micro1, 1, mean)
micro2_mean <- apply(micro2, 1, mean) 
#calculate fold change
foldchange <- log2(micro2_mean) - log2(micro1_mean)
hist(foldchange, xlab = "log2 Fold Change (Control vs 
Test)")
# t.test with p-vals
ttestmicro <- function(df, grp1, grp2) {
  x = df[grp1]
  y = df[grp2]
  x = as.numeric(x)
  y = as.numeric(y)  
  results = t.test(x, y)
  results$p.value
}
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rawpvalue = apply(micro, 1, ttestmicro, grp1 = c(1:23), 
grp2 = c(24:43))
hist(rawpvalue)
results = cbind(foldchange, rawpvalue)
results = as.data.frame(results)
results$probesets <- rownames(results)
rownames(results) <- probesets
library(ggplot2)
##Volcano Plot w categorical coloring to determine genes of 
interest 
logpval <- -log(rawpvalue)
res <- results
with(res, plot(foldchange, logpval, pch=20, main="Volcano 
plot", xlim=c(-3,3)))
# Add colored points: red if padj<0.05, orange of log2FC>1, 
green if both)
with(subset(res, rawpvalue<.05 ), points(foldchange, 
logpval,  pch=20, col="red"))
with(subset(res, abs(foldchange)>1), points(foldchange, 
logpval, pch=20, col="orange"))
with(subset(res, rawpvalue<.05 & abs(foldchange)>1), 
points(foldchange, logpval, pch=20, col="green"))
## Filter genes upregulated in healthy state (foldchange>1, 
-log10(pval)>1.3 == pval<0.05)
results_filtered = results[foldchange>1] #,
rawpvalue<0.05]]
## Filter genes upregulated in both healthy and disease 
states
Healthy_upreg = dplyr::filter(results, foldchange>1.5)
Healthy_upreg = dplyr::filter(results, rawpvalue<0.05 )  
## Choose -3 fold change to get smaller cluster of 
observations (< -2 have +2000)
diseased_upreg = dplyr::filter(results, foldchange< -3 )
diseased_upreg = dplyr::filter(results, rawpvalue<0.05 ) 
